Bowel Cancer Patients Live Longer Taking Xeloda - Analysis Confirms That Oral Xeloda Is Superior To IV 5-FU
A pre-planned multivariate analysis of the five-year follow-up data shows that patients receiving chemotherapy after-surgery to treat colon cancer, are more likely to live longer when taking the chemotherapy pill Xeloda (capecitabine), compared to those receiving 5-FU/FA intravenous (IV) chemotherapy.
